Drawing for FEMTOBIOMED CELLSHOT

USPTO serial 88144146

FEMTOBIOMED CELLSHOT

Reviewed by CopyMark Law Group

Reg. 5855206Status 702Registered
Filing date
Status date
Registration date
Sep 10, 2019
Examiner
RONCORONI, LAUREN R
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with FEMTOBIOMED CELLSHOT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James R Menker

James R Menker HOLLEY & MENKER, PAPO BOX 331937ATLANTIC BEACH, FL 32233United States

Goods and services

ClassDescriptionStatusFirst use
009DNA chips; computer software for measuring and analyzing interfacial energy; interfacial energy measuring and analyzing apparatus in the nature of force measurement products, namely, digital force gauges, digital torque gauges and manual and motorized test stands used therewith sold as a unit with the gauges, tension testers; optical profilers; data processing apparatus in the nature of digitizers being measuring instrumentation and apparatus; digital measuring apparatus in the nature of digital multimeters; laboratory equipment and supplies, namely, incubators for cell culture; bioreactor for cell culturing; cell measuring apparatus in the nature of electronic apparatus for electrophysiological measurement of cells; free fatty acid measuring and analyzing apparatus for laboratory use being research laboratory analyzers for measuring and analyzing blood and other bodily fluids; intracellular material injector for laboratory use in the nature of injection instrument with needles, needle-based and needle-free injection systems; computer software for measuring and analyzing free fatty acid; gene analyzing and extracting devices, namely, laboratory apparatus and instruments for extracting DNA; laboratory apparatus and instruments, namely, gene amplifiers in the nature of DNA microarrays; computer software for diagnosing diseases for medical purposes; measuring devices, electric, namely, electronic apparatus for electrophysiological measurement of cells; computer software for measuring and analyzing contact angle; contact angle measuring and analyzing apparatus, namely, angle finders; precision measuring apparatus, namely, laboratory equipment and supplies, namely, calipers; surveying instrumentsACTIVE—
010Apparatus for use in medical analysis, namely, medical diagnostic apparatus for testing DNA and RNA samples; diagnostic apparatus for medical purposes for testing blood sugar levels, cancer cells, and DNA; diabetes measuring apparatus being blood glucose meter; medical immunoassay apparatus, namely, immunochemical testing apparatus for medical use; immunoassay apparatus for diagnostic in the nature of medical diagnostic apparatus for detecting cancer, medical diagnostic apparatus for testing DNA and RNA samples; cell culture instruments for medical use, namely, cell culture chambers; free fatty acid measuring device being medical instruments; measuring instruments for medical purposes for measuring and displaying cancer cells, DNA, blood cells and extra cellular contents; cell testing apparatus in the nature of medical diagnostic apparatus for testing cancer cells, DNA, blood cells and extra cellular contents; intracellular material injector for medical purposes in the nature of injection instrument with needles, needle-based and needle-free injection systems; medical apparatus and instruments for monitoring vital signs, for use in orthopedic surgery; apparatus for analysing substances for medical purposes, namely, blood and cell analyzers for medical diagnostics; test tubes for cell separation for medical purposes in the nature of blood testing apparatus, namely, blood sampling tubes; apparatus for the regeneration of stem cells for medical purposes; gene and genetic testing apparatus in the nature of apparatus for DNA and RNA testing for medical purposes; blood testing apparatus; infusion apparatus for therapeutic purposes, namely, medical apparatus, namely, infusion devices for administering drugsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 12, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 12, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 12, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 8, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Sep 10, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 10, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 25, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 25, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 5, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 20, 2019ALIEASSIGNED TO LIE—
May 7, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 2, 2019XAECEXAMINER'S AMENDMENT ENTERED—
May 2, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
May 2, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
May 2, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 6, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 6, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 6, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 25, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 25, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2019DOCKASSIGNED TO EXAMINER—
Oct 15, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 9, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance